Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Perry M Elliott

Showing results (241-250 of 292) with videos related to

Pageof 30
Sort By:
Journal of the American College of Cardiology|August 27, 2025
Effects of Mavacamten on Cardiac Biomarkers in Nonobstructive Hypertrophic Cardiomyopathy: Insights From the ODYSSEY-HCM TrialMilind Y Desai, Iacopo Olivotto, Theodore Abraham, et al.
European Journal of Heart Failure|June 19, 2019
Definition and treatment of arrhythmogenic cardiomyopathy: an updated expert panel reportPerry M Elliott, Aris Anastasakis, Angeliki Asimaki, et al.
Journal of the American College of Cardiology|January 28, 2012
Risk factors for malignant ventricular arrhythmias in lamin a/c mutation carriers a European cohort studyIngrid A W van Rijsingen, Eloisa Arbustini, Perry M Elliott, et al.
European Journal of Preventive Cardiology|November 1, 2024
Arrhythmic risk stratification in patients with left ventricular ring-like scarVanda Parisi, Maddalena Graziosi, Luis R Lopes, et al.
European Heart Journal|March 4, 2026
Aficamten in symptomatic obstructive hypertrophic cardiomyopathy: the FOREST-HCM long-term studyAlbree Tower-Rader, Ahmad Masri, Michael E Nassif, et al.
Molecular Genetics and Metabolism|July 19, 2018
European expert consensus statement on therapeutic goals in Fabry diseaseChristoph Wanner, Michael Arad, Ralf Baron, et al.
Circulation. Genomic and Precision Medicine|February 15, 2018
Improving Interpretation of Cardiac Phenotypes and Enhancing Discovery With Expanded Knowledge in the Gene OntologyRuth C Lovering, Paola Roncaglia, Douglas G Howe, et al.
European Heart Journal|June 29, 2017
Diagnosis and management of myocardial involvement in systemic immune-mediated diseases: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial DiseaseAlida L P Caforio, Yehuda Adler, Carlo Agostini, et al.
Frontiers in Physiology|August 29, 2024
The arrhythmic substrate of hypertrophic cardiomyopathy using ECG imagingJi-Jian Chow, Kevin M W Leong, Matthew Shun-Shin, et al.
European Heart Journal|January 30, 2018
The Cardiomyopathy Registry of the EURObservational Research Programme of the European Society of Cardiology: baseline data and contemporary management of adult patients with cardiomyopathiesPhilippe Charron, Perry M Elliott, Juan R Gimeno, et al.
Pageof 30

Showing results (241-250 of 292) with videos related to

Sort By:
Pageof 30
Journal of the American College of Cardiology|August 27, 2025
Effects of Mavacamten on Cardiac Biomarkers in Nonobstructive Hypertrophic Cardiomyopathy: Insights From the ODYSSEY-HCM TrialMilind Y Desai, Iacopo Olivotto, Theodore Abraham, et al.
European Journal of Heart Failure|June 19, 2019
Definition and treatment of arrhythmogenic cardiomyopathy: an updated expert panel reportPerry M Elliott, Aris Anastasakis, Angeliki Asimaki, et al.
Journal of the American College of Cardiology|January 28, 2012
Risk factors for malignant ventricular arrhythmias in lamin a/c mutation carriers a European cohort studyIngrid A W van Rijsingen, Eloisa Arbustini, Perry M Elliott, et al.
European Journal of Preventive Cardiology|November 1, 2024
Arrhythmic risk stratification in patients with left ventricular ring-like scarVanda Parisi, Maddalena Graziosi, Luis R Lopes, et al.
European Heart Journal|March 4, 2026
Aficamten in symptomatic obstructive hypertrophic cardiomyopathy: the FOREST-HCM long-term studyAlbree Tower-Rader, Ahmad Masri, Michael E Nassif, et al.
Molecular Genetics and Metabolism|July 19, 2018
European expert consensus statement on therapeutic goals in Fabry diseaseChristoph Wanner, Michael Arad, Ralf Baron, et al.
Circulation. Genomic and Precision Medicine|February 15, 2018
Improving Interpretation of Cardiac Phenotypes and Enhancing Discovery With Expanded Knowledge in the Gene OntologyRuth C Lovering, Paola Roncaglia, Douglas G Howe, et al.
European Heart Journal|June 29, 2017
Diagnosis and management of myocardial involvement in systemic immune-mediated diseases: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial DiseaseAlida L P Caforio, Yehuda Adler, Carlo Agostini, et al.
Frontiers in Physiology|August 29, 2024
The arrhythmic substrate of hypertrophic cardiomyopathy using ECG imagingJi-Jian Chow, Kevin M W Leong, Matthew Shun-Shin, et al.
European Heart Journal|January 30, 2018
The Cardiomyopathy Registry of the EURObservational Research Programme of the European Society of Cardiology: baseline data and contemporary management of adult patients with cardiomyopathiesPhilippe Charron, Perry M Elliott, Juan R Gimeno, et al.
Pageof 30